Moomoo AI 已提取核心訊息
On January 11, 2024, Exicure, Inc., a biotechnology company listed on The Nasdaq Stock Market, received a notification of delinquency from Nasdaq for failing to hold an annual meeting of shareholders within twelve months of the end of its fiscal year on December 31, 2022. This non-compliance with Nasdaq Listing Rule 5620(a) has prompted Nasdaq to require Exicure to submit a plan within 45 days to address how it will regain compliance. Exicure has the opportunity to request an extension of up to 180 days, or until June 28, 2024, to meet the listing requirements. The company has expressed its intention to submit a compliance plan and seek the extension.
On January 11, 2024, Exicure, Inc., a biotechnology company listed on The Nasdaq Stock Market, received a notification of delinquency from Nasdaq for failing to hold an annual meeting of shareholders within twelve months of the end of its fiscal year on December 31, 2022. This non-compliance with Nasdaq Listing Rule 5620(a) has prompted Nasdaq to require Exicure to submit a plan within 45 days to address how it will regain compliance. Exicure has the opportunity to request an extension of up to 180 days, or until June 28, 2024, to meet the listing requirements. The company has expressed its intention to submit a compliance plan and seek the extension.
2024年1月11日，在納斯達克股票市場上市的生物技術公司Exicure, Inc. 因未能在2022年12月31日財政年度結束後的十二個月內舉行年度股東大會而收到納斯達克的拖欠通知。這種不遵守納斯達克上市規則5620（a）的行爲促使納斯達克要求Exicure在45天內提交計劃，以解決其如何恢復合規的問題。Exicure有機會申請延長最多180天，或延至2024年6月28日，以滿足上市要求。該公司已表示打算提交合規計劃並尋求延期。
2024年1月11日，在納斯達克股票市場上市的生物技術公司Exicure, Inc. 因未能在2022年12月31日財政年度結束後的十二個月內舉行年度股東大會而收到納斯達克的拖欠通知。這種不遵守納斯達克上市規則5620（a）的行爲促使納斯達克要求Exicure在45天內提交計劃，以解決其如何恢復合規的問題。Exicure有機會申請延長最多180天，或延至2024年6月28日，以滿足上市要求。該公司已表示打算提交合規計劃並尋求延期。
有用
沒用